Advertisements
“Indirect Tax I Indirect Tax Litigation I Customs & FTP I Central Licensing I Arbitration I Advisory”
Dated: 27.12.2025
NPPA Fixes Retail Prices for 37 Essential Medicines
The National Pharmaceutical Pricing Authority (NPPA), under the Ministry of Chemicals and Fertilizers, has issued a new price notification on December 24, 2025, under the Drugs (Prices Control) Order, 2013 (DPCO, 2013). This notification, S.O. 5975(E), outlines the retail prices for various pharmaceutical formulations manufactured and marketed by specific companies. The order is a significant step in ensuring affordability and accessibility of essential medicines for the public while maintaining compliance with government regulations.
Key Highlights of the Notification
- Retail Price Fixation: The NPPA has fixed the retail prices for 37 pharmaceutical formulations, exclusive of Goods and Services Tax (GST). These prices are applicable to the specific manufacturers and marketing companies listed in the notification. The retail price for each formulation is detailed in the table provided in the notification.
- GST Applicability: Manufacturers are allowed to add GST to the retail price only if it has been paid or is payable to the government. This ensures transparency in pricing and prevents unjustified price hikes.
- Compliance with DPCO, 2013: The retail price fixation is in accordance with paragraph 11 of the DPCO, 2013. Manufacturers are required to issue a price list in Form-V from the date of notification and submit it to the NPPA through the Integrated Pharmaceutical Database Management System (IPDMS). A copy of the price list must also be provided to the State Drug Controller and dealers.
- Retailer and Dealer Obligations: As per paragraph 24(4) of DPCO, 2013, retailers and dealers must display the price list and any supplementary price lists in a conspicuous part of their premises. This ensures that the prices are easily accessible to consumers.
- Penalties for Non-Compliance: If any manufacturer or marketing company fails to comply with the retail price specified in the notification, they will be liable to deposit the overcharged amount along with interest under the provisions of DPCO, 2013 and the Essential Commodities Act, 1955.
- Supersession of Previous Price Orders: Any previous price orders for the specified formulations and manufacturers/marketing companies are superseded by this notification. This ensures uniformity and clarity in pricing.
Detailed Table of Fixed Retail Prices
The notification includes a comprehensive table listing the formulations, their strengths, units, manufacturers, marketing companies, and the fixed retail prices. Some notable entries include:
| Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
| (1) | (2) | (3) | (4) | (5) | (6) |
| 1 | Aceclofenac & Paracetamol Tablets | Each film coated tablet contains: Aceclofenac IP 100 mg Paracetamol IP 325 mg | 1 Tablet | M/s Shiva Biogenetic Pharmaceuticals Pvt. Ltd./ M/s Softdeal Pharmaceutical Pvt. Ltd. | 5.46 |
| 2 | Albendazole & Ivermectin suspension | Each 5ml contains: Albendazole IP 200 mg Ivermectin IP 3 mg | 1 ml | M/s Yacca Lifesciences Pvt. Ltd./ M/s Wockhardt Ltd. | 1.39 |
| 3 | Atorvastatin & Ezetimibe Tablets | Each Film Coated Tablet Contains: Atorvastatin Calcium IP Eq. to Atorvastatin 80mg Ezetimibe IP 10mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Eris Lifesciences Ltd. | 36.12 |
| 4 | Bilastine & Montelukast Tablets | Each film coated bilayered tablet contains: Bilastine IP 40 mg Montelukast Sodium IP eq. to Montelukast10mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd./ M/s Cipla Ltd. | 22.78 |
| 5 | Bisoprolol fumarate & Telmisartan Tablets | Each film coated Bi-layered tablet contains: Bisoprolol fumarate IP 2.5 mg Telmisartan IP 40 mg | 1 Tablet | M/s Mascot Health Series Pvt. Ltd./ M/s Primus Remedies Pvt. Ltd. | 10.50 |
| 6 | Bisoprolol fumarate & Telmisartan Tablets | Each film coated Bi-layered tablet contains: Bisoprolol fumarate IP 5 mg Telmisartan IP 40 mg | 1 Tablet | M/s Mascot Health series Pvt. Ltd./ M/s Primus Remedies Pvt. Ltd. | 12.00 |
| 7 | Bisoprolol fumarate & Telmisartan Tablets | Each uncoated bilayered tablet contains: Bisoprolol fumarate IP 2.5 mg Telmisartan IP 40 mg | 1 Tablet | M/s Windlas Biotech Ltd./ M/s Dr. Reddy’s Laboratories Ltd. | 10.00 |
| 8 | Bisoprolol fumarate & Telmisartan Tablets | Each uncoated bilayered tablet contains: Bisoprolol fumarate IP 5 mg Telmisartan IP 40 mg | 1 Tablet | M/s Windlas Biotech Ltd./ M/s Dr. Reddy’s Laboratories Ltd. | 12.18 |
| 9 | Calcium Aspartate, Calcium Orotate, Calcitriol, Minerals & vitamins tablets | Each Film Coated Tablet Contains: Calcium Aspartate 500 mg Calcium Orotate 500 mg Calcitriol IP 0.25 mcg Zinc (As Zinc Sulphate Monohydrate) IP 7.5 mg Magnesium Hydroxide IP 50 mg Hydroxocobalamin IP 100 mcg Folic Acid IP 1.5 mg | 1 Tablet | M/s Troikaa Pharmaceuticals Ltd. | 17.78 |
| 10 | Calcium, Vitamin D3, Methyl cobalamin, L-Methyl folate Calcium & Pyridoxal-5-Phosphate Tablets | Each film coated tablet contains: Calcium Carbonate IP 1250 mg Eq. to Elemental Calcium 500 mg Vitamin D3 IP 2000 IU Methyl cobalamin IP 1500 mcg L-Methyl folate Calcium 1 mg Pyridoxal-5- Phosphate 20 mg | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd. M/s Pharmed Ltd. | 19.24 |
| 11 | Cholecalciferol (Vitamin D3) Oral Solution | Each 5 ml contains: Cholecalciferol IP (In Nano Droplet form) 60000 IU | 1 ml | M/s Ravenbhel Healthcare Pvt. Ltd./ M/s Troikaa Pharmaceuticals Ltd. | 15.60 |
| 12 | Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Syrup | Each 5 ml contains: Dextromethorphan Hydrobromide IP 15 mg Phenylephrine Hydrochloride IP 5mg Chlorpheniramine Maleate IP 2 mg | 1 ml | M/s East African (I) Overseas / M/s SRK Puremed LLP | 0.98 |
| 13 | Levocetirizine Dihydrochloride & Montelukast Sodium Syrup | Each 5ml contains: Levocetirizine Dihydrochloride IP 2.5 mg Montelukast Sodium IP eq. to Montelukast 4 Mg | 1 ml | M/s Tirupati Medicare Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd. | 1.67 |
| 14 | Mefenamic acid & Paracetamol oral suspension | Each 5 ml contains: Mefenamic acid IP 50 mg Paracetamol IP 125 mg | 1 ml | M/s East African (I) Overseas / M/s SRK Puremed LLP | 0.77 |
| 15 | Mefenamic acid & Paracetamol oral suspension | Each 5 ml contains: Mefenamic acid IP 100 mg Paracetamol IP 250 mg | 1 ml | M/s East African (I) Overseas / M/s SRK Puremed LLP | 0.92 |
| 16 | Mefenamic acid & Paracetamol Tablets | Each uncoated tablet contains: Mefenamic Acid IP 500mg Paracetamol IP 325mg | 1 Tablet | M/s East African (I) Overseas / M/s SRK Puremed LLP | 3.91 |
| 17 | Mefenamic Acid & Paracetamol Suspension | Each 5 ml contains: Mefenamic Acid IP 100 mg Paracetamol IP 250 mg | 1 ml | M/s Skymap Pharmaceuticals Pvt. Ltd./ M/s Glensmith Labs Pvt. Ltd. | 0.90 |
| 18 | Mefenamic Acid & Paracetamol Suspension | Each 5 ml contains: Mefenamic Acid IP 100 mg Paracetamol IP 250 mg | 1 ml | M/s Skymap Pharmaceuticals Pvt. Ltd./ M/s Jagsonpal Pharmaceuticals Ltd. | 0.90 |
| 19 | Meropenem & Sulbactam for Injection | Each vial contains: Sulbactam Sodium (Sterile) IP Equivalent to Sulbactam 500 mg Meropenem (Sterile) IP Equivalent to Anhydrous Meropenem 1000 mg Sodium Carbonate (As buffer) (Sterile) IP Equivalent to Sodium 90.2 mg | 1 Vial | M/s Gufic Biosciences Ltd./ M/s Intas Pharmaceuticals Ltd. | 1500.00 |
| 20 | Myo-Inositol & Metformin Hydrochloride (SR) Tablets | Each Film Coated Bilayered Tablet Contains: Myo-Inositol IP 600 mg Metformin Hydrochloride IP 500 mg (As sustained release) | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. M/s Mankind Pharma Ltd. | 23.59 |
| 21 | Myo-Inositol & Metformin Hydrochloride (SR) Tablets | Each Film Coated Bilayered Tablet Contains: Myo-Inositol IP 600 mg Metformin Hydrochloride IP 500 mg (As sustained release) | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. M/s Emcure Pharmaceuticals Ltd. | 23.59 |
| 22 | Myo-Inositol & Metformin Hydrochloride (SR) Tablets | Each Film Coated Bilayered Tablet Contains: Myo-Inositol IP 600 mg Metformin Hydrochloride IP 500 mg (As sustained release) | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. M/s Torrent Pharmaceuticals Ltd. | 23.59 |
| 23 | Moxifloxacin Hydrochloride & Ketorolac Tromethamine Ophthalmic solution | Composition: Moxifloxacin Hydrochloride IP Eq. to Moxifloxacin 0.5% w/v Ketorolac Tromethamine IP 0.5 % w/v Preservative: Benzalkonium Chloride solution IP 0.01% w/v | 1 ml | M/s East African (I) Overseas / M/s Torrent Pharmaceuticals Ltd. | 15.00 |
| 24 | Multiple Electrolytes and 5% Dextrose Injection Type-I USP | Each 100 mL contains: Sodium Chloride IP 526 mg Sodium Gluconate USP 502 mg Sodium Acetate Trihydrate IP 368 mg Potassium Chloride IP 37 mg Magnesium Chloride Hexahydrate IP 30 mg Dextrose Monohydrate IP 5000 mg | 1 pack of 500 mL | M/s Otsuka Pharmaceutical India Pvt. Ltd. | 133.97 |
| 25 | Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Tablets | Each uncoated tablet contains: Paracetamol IP 500 mg Phenylephrine Hydrochloride IP 10 mg Chlorpheniramine Maleate IP 2 mg | 1 Tablet | M/s East African (I) Overseas / M/s Intas Pharmaceuticals Ltd. | 5.34 |
| 26 | Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Suspension | Each 5 ml contains: Paracetamol IP 250 mg Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg | 1 ml | M/s Mascot Health Series Pvt. Ltd./ M/s Stedman Pharmaceuticals Pvt. Ltd. | 1.36 |
| 27 | Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Suspension | Each 5 ml contains: Paracetamol IP 125 mg Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg | 1 ml | M/s Mascot Health Series Pvt. Ltd./ M/s Macleods Pharmaceuticals Ltd. | 1.31 |
| 28 | Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Suspension | Each 5 ml contains: Paracetamol IP 250 mg Phenylephrine Hydrochloride IP 5mgChlorpheniramine Maleate IP 2mg | 1 ml | M/s Mascot Health Series Pvt. Ltd./ M/s Macleods Pharmaceuticals Ltd. | 1.36 |
| 29 | Paroxetine (CR) & Clonazepam Capsules | Each hard gelatin capsule contains: Paroxetine Hydrochloride Hemihydrate IP Eq. to Paroxetine 12.5 mg (as enteric coated controlled release tablet) Clonazepam IP 0.25 mg (as uncoated Clonazepam Tablets IP) | 1 Capsule | M/s Windlas Biotech Ltd./ M/s Ipca Laboratories Ltd. | 15.53 |
| 30 | Phenylephrine Hydrochloride & Chlorpheniramine Maleate Syrup | Each 5ml contains: Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg | 1 ml | M/s East African (I) Overseas/ M/s SRK Puremed LLP | 0.95 |
| 31 | Povidone-Iodine & Metronidazole Ointment | Composition: Povidone-Iodine IP 5 % w/w (0.5 % w/w available Iodine) Metronidazole IP 1 % w/w | 1 GM | M/s Stedman Pharmaceuticals Pvt. Ltd. | 4.00 |
| 32 | Tropicamide, Phenylephrine Hydrochloride & Lidocaine Hydrochloride Injection (Intra cameral Injection) | Each ml contains: Tropicamide IP 0.2 mg Phenylephrine Hydrochloride IP 3.1 mg Lidocaine Hydrochloride IP 10 mg | 1 ml AMPOULE | M/s Samarth Life Sciences Pvt. Ltd. | 124.28 |
| 33 | Vitamin D3 nano syrup | Each 5ml Contains: Cholecalciferol IP 60,000 IU (in Nano Droplet Form) | 1 ml | M/s Unicure India Ltd./ M/s Obsurge Biotech Ltd. | 15.60 |
| 34 | Dapagliflozin and Telmisartan Tablets | Each film coated tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10 mg Telmisartan IP 40 mg | 1 Tablet | M/s Exemed Pharmaceuticals/ M/s Glenmark Pharmaceuticals Ltd. | 18.27 |
| 35 | Glycopyrronium, Formoterol Fumarate, Budesonide Inhalation Suspension | Each Smartule contains: Glycopyrrolate IP Eq. to Glycopyrronium 25 mcg Formoterol Fumarate Dihydrate IP Eq. to Formoterol Fumarate 20 mcg Budesonide IP 500 mcg | 1 ml | M/s Glenmark Pharmaceuticals Ltd. | 49.00 |
| 36 | Sitagliptin, Gliclazide (SR), Metformin Hydrochloride (SR) Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg Gliclazide IP 60 mg (As sustained release) Metformin Hydrochloride IP 500mg (As sustained release) | 1 Tablet | M/s Eris Lifesciences Ltd. | 22.91 |
| 37 | Paracetamol, Chlorpheniramine Maleate Tablets | Each Uncoated Tablet Contains: Paracetamol IP 325 mg Chlorpheniramine Maleate IP 2 mg | 1 Tablet | M/s Indoco Remedies Ltd. | 6.80 |
The table provides detailed information for all 37 formulations, ensuring transparency and clarity for manufacturers, retailers, and consumers.
Implications for Stakeholders
This notification has significant implications for various stakeholders:
- Manufacturers and Marketing Companies: Manufacturers and marketing companies must adhere to the fixed retail prices and comply with all statutory requirements, including obtaining necessary manufacturing licenses from the Central/State Licensing Authority. They are also required to submit price lists to the NPPA and other relevant authorities.
- Retailers and Dealers: Retailers and dealers must display the price lists prominently in their premises to ensure consumers have easy access to pricing information.
- Consumers: Consumers benefit from standardized pricing, ensuring affordability and preventing overcharging for essential medicines.
Conclusion
The NPPA’s latest price notification is a crucial step in regulating the pharmaceutical industry and ensuring the availability of affordable medicines. By fixing retail prices and enforcing compliance with DPCO, 2013, the government aims to protect consumer interests while maintaining transparency in the pharmaceutical market. Manufacturers, retailers, and dealers must adhere to the guidelines to avoid penalties and contribute to the larger goal of accessible healthcare for all.
Listen to this on our #YouTube Channel
In case you face any issues related to Indirect Tax-Customs, GST, Foreign Trade Policy (FTP), Arbitration matters and Central Licensing and related advisory matters in India then please feel free to get in touch with SJ EXIM Services.
We offer Legal advice and litigation support in matters related to Indirect Tax-Customs, FTP, other Indirect Tax matters & Arbitration law, all sorts of Central licensing and related matters. Come and explore the new way of doing business with us!
Source: Ministry of Chemicals and Fertilizers
Handy Download:
Connect with us for more-
@ Team S J EXIM SERVICES, New Delhi, IN
CP: Ms. Shubhra Jha, Founder
Tel: +91-11-4999 2707 I +91-9999005693
Web: www.sjexim.services
EMAIL: operations@sjexim.services I shubhra@sjexim.services
Facebook: www.facebook.com/sjeximservices
LinkedIn: https://www.linkedin.com/company/90794255/admin/feed/posts/
YouTube: https://www.youtube.com/@sjeximIndia
Subscribe our WhatsApp Channel: https://whatsapp.com/channel/0029VaTxDT8JZg4CHEOSoK47
Subscribe our Telegram Channel: https://t.me/sjeximindia
Leave a ReplyCancel reply